Android Apple

DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39%

By Yahoo! Finance   |   5 months ago
DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 50% ownership, insiders own 39%

Individual investors hold significant control over DiaMedica Therapeutics, influencing management and governance decisions. Major shareholders include Thomas von Koch, Jan Stahlberg, and Richard Jacinto. Institutional ownership and analyst sentiments also play a role in the company's performance.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.